Drug Utilization Review Board
Meeting Agenda
Thursday, June 11, 2026
7:15 a.m. to 8:30 a.m.
Google Meet joining info
Video call link: meet.google.com/qbv-rjpz-fst
Or dial: (US) +1 314-474-3014 PIN: 334 496 072#
Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov at least one week prior to the meeting. Public comments will be limited to three minutes per speaker or organization due to time constraints.
1) Call to order - Sharon Weinstein, MD
a) Welcome
b) Review and Approval of Minutes
2) Prior Authorization Updates - Luis Moreno, PharmD
3) P&T Committee Update - Ngan Huynh, PharmD
4) Review Topic
a) Single Maintenance and Reliever Therapy for Asthma Management - Monet Luloh, PharmD
i) Committee Discussion/Questions
ii) Committee Action
5) Public Comment
6) Review New Prior Authorization Criteria
a) Neonatal Fc Receptor Antagonists (Imaavy, Rystiggo, Vyvgart, and Vyvgart Hytrulo) - Luis Moreno, PharmD
i) Committee Discussion/Questions
ii) Committee Action
b) Vykat XR (diazoxide choline) - Iris Wan, PharmD
i) Committee Discussion/Questions
ii) Committee Action
c) Verquvo (vericiguat) - Kyu Yun Park, PharmD
i) Committee Discussion/Questions
ii) Committee Action
7) Next Meeting
a) Date: July 9, 2026
b) Topic: New Prior Authorization Reviews
8) Adjourned - Sharon Weinstein, MD
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/qbv-rjpz-fst
Or dial: (US) +1 314-474-3014 PIN: 334 496 072#